TP53 and ovarian carcinoma: Some studies have investigated the association between TP53 mutations and platinum responses in ovarian cancer; however, the results have been discordant and derived from heterogenous studies, neither of which accounted for the BRCA mutation status [3,14,18,30,31,32].